前收市價 | 27.30 |
開市 | 27.48 |
買盤 | 27.21 x 900 |
賣出價 | 27.78 x 1000 |
今日波幅 | 27.08 - 27.52 |
52 週波幅 | 21.83 - 37.98 |
成交量 | |
平均成交量 | 916,504 |
市值 | 3.084B |
Beta 值 (5 年,每月) | 1.52 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -0.71 |
業績公佈日 | 2023年10月31日 - 2023年11月06日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 46.88 |
Evolent Health, Inc. (NYSE:EVH) Q2 2023 Earnings Call Transcript August 2, 2023 Evolent Health, Inc. misses on earnings expectations. Reported EPS is $0.02 EPS, expectations were $0.09. Operator: Welcome to the Evolent Earnings Conference Call for the Quarter Ending June 30, 2023. As a reminder, this conference call is being recorded. Your host for the […]
Evolent Health Inc (NYSE: EVH) reported Q4 adjusted EPS of $0.10, missing the consensus of $0.16, compared to $0.08 a year ago. Revenues increased 54% Y/Y to $382.43 million, beating the consensus of $372.93 million. Total Lives on the Platform of 20.6 million as of Dec. 31, 2022, compared to 17.7 million a year ago. Total cases managed during the quarter within surgical management and advanced care planning totaled 15.7k, yielding an average per case revenue of $2.8k. Guidance: Evolent Health s
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. Small-cap stocks posted solid returns in the fourth quarter for the first time in 2022. The Russell 2000 Growth Index was up 4.11% trailing the Russell 2000 […]